A Novel MATLAB®-Algorithm-Based Video Analysis to Quantitatively Determine Solution Creeping in Intact Pharmaceutical Glass Vials.

Contact angle Creeping Critical micelle concentration Fogging Glass vial inner surface Lyophilisation MATLAB® algorithm Polysorbate Vial process Wetting

Journal

European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V
ISSN: 1873-3441
Titre abrégé: Eur J Pharm Biopharm
Pays: Netherlands
ID NLM: 9109778

Informations de publication

Date de publication:
Sep 2022
Historique:
received: 18 05 2022
revised: 05 08 2022
accepted: 07 08 2022
pubmed: 13 8 2022
medline: 11 9 2022
entrez: 12 8 2022
Statut: ppublish

Résumé

During the filling process of a biopharmaceutical drug product (DP), a liquid DP film might creep up the inner vial wall which is barely discernible, appears as milky-white haze after lyophilisation and is known as fogging. Creeping and fogging are mainly dependent on the primary packaging material surface and its hydration, vial preparation process as well as DP composition. The occurrence of both can impede visual inspection and might lead to DP rejection. Hence, our studies focused on the early detection of liquid solution and glass vial surface interaction directly after filling. For a fast and highly sensitive evaluation a novel video-based analysis was used. To our knowledge, this is the first time a MATLAB®-algorithm-based video analysis was applied to quantitatively determine creeping time-resolved. Furthermore, creeping in dependence of vial processing sites, surfactant type and concentration, filling temperature, and vial format were investigated. The results were verified using orthogonal conventional methods such as surface tension, wetting behaviour, and contact angle measurements, as well as ToF-SIMS, ICP-MS, and SEM. Additionally, the methods applied were assessed regarding their cross-validation capability. The observations indicate that the vial preparation process can have a pronounced impact on alteration of the glass vial surface and related creeping behaviour of the filled solution.

Identifiants

pubmed: 35961565
pii: S0939-6411(22)00169-2
doi: 10.1016/j.ejpb.2022.08.003
pii:
doi:

Substances chimiques

Pharmaceutical Preparations 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

117-130

Informations de copyright

Copyright © 2022 The Authors. Published by Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Daniel Molnar (D)

Boehringer Ingelheim Pharma GmbH & Co. KG, Formulation and Process Development Biologicals Late Stage, 88397 Biberach, Germany. Electronic address: daniel.molnar@boehringer-ingelheim.com.

Martina Röhm (M)

Boehringer Ingelheim Pharma GmbH & Co. KG, Formulation and Process Development Biologicals Late Stage, 88397 Biberach, Germany.

Johannes Wutz (J)

Boehringer Ingelheim Pharma GmbH & Co. KG, Formulation and Process Development Biologicals Late Stage, 88397 Biberach, Germany.

Ingrid Rivec (I)

Boehringer Ingelheim Pharma GmbH & Co. KG, Formulation and Process Development Biologicals Late Stage, 88397 Biberach, Germany; Institute of Applied Biotechnology, Faculty for Biotechnology, Biberach University of Applied Sciences, 88400 Biberach, Germany; Faculty for Natural Sciences, University of Ulm, Albert-Einstein-Allee 11, 89081 Ulm, Germany.

Annika Michel (A)

Boehringer Ingelheim Pharma GmbH & Co. KG, Formulation and Process Development Biologicals Late Stage, 88397 Biberach, Germany; Institute of Applied Biotechnology, Faculty for Biotechnology, Biberach University of Applied Sciences, 88400 Biberach, Germany; Faculty for Natural Sciences, University of Ulm, Albert-Einstein-Allee 11, 89081 Ulm, Germany.

Gina Klotz (G)

Boehringer Ingelheim Pharma GmbH & Co. KG, Formulation and Process Development Biologicals Late Stage, 88397 Biberach, Germany; Institute of Process Engineering in Life Sciences, Section IV: Biomolecular Separation Engineering, Karlsruhe Institute of Technology, 76131 Karlsruhe, Germany.

Jürgen Hubbuch (J)

Institute of Process Engineering in Life Sciences, Section IV: Biomolecular Separation Engineering, Karlsruhe Institute of Technology, 76131 Karlsruhe, Germany.

Katharina Schindowski (K)

Institute of Applied Biotechnology, Faculty for Biotechnology, Biberach University of Applied Sciences, 88400 Biberach, Germany.

Ingo Presser (I)

Boehringer Ingelheim Pharma GmbH & Co. KG, Formulation and Process Development Biologicals Late Stage, 88397 Biberach, Germany.

Articles similaires

Selecting optimal software code descriptors-The case of Java.

Yegor Bugayenko, Zamira Kholmatova, Artem Kruglov et al.
1.00
Software Algorithms Programming Languages
Humans Pharmaceutical Preparations Drug Utilization Prescription Drugs
1.00
Humans Magnetic Resonance Imaging Brain Infant, Newborn Infant, Premature
Humans Algorithms Software Artificial Intelligence Computer Simulation

Classifications MeSH